Exact Mass: 236.0815312
Exact Mass Matches: 236.0815312
Found 207 metabolites which its exact mass value is equals to given mass value 236.0815312,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Didanosine
A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by a hydrogen. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. Didanosine is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA by binding to reverse transcriptase; ddI is then metabolized to dideoxyadenosine triphosphate, its putative active metabolite. [PubChem] J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AF - Nucleoside and nucleotide reverse transcriptase inhibitors C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97452 - Nucleoside Reverse Transcriptase Inhibitor D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D009676 - Noxae > D000963 - Antimetabolites > D015224 - Dideoxynucleosides D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors C254 - Anti-Infective Agent > C281 - Antiviral Agent CONFIDENCE standard compound; EAWAG_UCHEM_ID 3135 Didanosine (2',3'-Dideoxyinosine; ddI) is a a potent and orally active dideoxynucleoside analogue, and also is a potent nucleoside reverse transcriptase inhibitor. Didanosine shows antiretroviral activity for HIV[1][2][3].
L-Formylkynurenine
C11H12N2O4 (236.07970319999998)
This compound belongs to the family of Butyrophenones. These are compounds containing 1-phenylbutan-1-one moiety.
Buturon
CONFIDENCE standard compound; INTERNAL_ID 196; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8604; ORIGINAL_PRECURSOR_SCAN_NO 8601 CONFIDENCE standard compound; INTERNAL_ID 196; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8543; ORIGINAL_PRECURSOR_SCAN_NO 8540 CONFIDENCE standard compound; INTERNAL_ID 196; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3999; ORIGINAL_PRECURSOR_SCAN_NO 3997 CONFIDENCE standard compound; INTERNAL_ID 196; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8573; ORIGINAL_PRECURSOR_SCAN_NO 8571 CONFIDENCE standard compound; INTERNAL_ID 196; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8609; ORIGINAL_PRECURSOR_SCAN_NO 8604 CONFIDENCE standard compound; INTERNAL_ID 196; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4000; ORIGINAL_PRECURSOR_SCAN_NO 3997 CONFIDENCE standard compound; INTERNAL_ID 196; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8607; ORIGINAL_PRECURSOR_SCAN_NO 8605 CONFIDENCE standard compound; INTERNAL_ID 196; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4014; ORIGINAL_PRECURSOR_SCAN_NO 4010 CONFIDENCE standard compound; INTERNAL_ID 196; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4010; ORIGINAL_PRECURSOR_SCAN_NO 4007 CONFIDENCE standard compound; INTERNAL_ID 196; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4035; ORIGINAL_PRECURSOR_SCAN_NO 4033
N'-Formylkynurenine
C11H12N2O4 (236.07970319999998)
Plays an especially improtant role in photobiological responses. The excited states of N-formylkynurenine react to produce hydroxyl radicals. [HMDB] Plays an especially improtant role in photobiological responses. The excited states of N-formylkynurenine react to produce hydroxyl radicals.
Methionyl-Serine
Methionyl-Serine is a dipeptide composed of methionine and serine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
Serylmethionine
Serylmethionine is a dipeptide composed of serine and methionine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
Acetamide, N-[4-[[(aminothioxomethyl)hydrazono]methyl]phenyl]-
C10H12N4OS (236.07317819999997)
4-Acetylaminohippuric acid
C11H12N2O4 (236.07970319999998)
Carbazochrome
B - Blood and blood forming organs > B02 - Antihemorrhagics > B02B - Vitamin k and other hemostatics D006401 - Hematologic Agents > D003029 - Coagulants > D006490 - Hemostatics C78275 - Agent Affecting Blood or Body Fluid > C78311 - Hemostatic Agent Carbazochrome is a capillary stabiliser and used for the research of haemorrhage. Carbazochrome is an antihemorrhagic agent[1].
(2S)-4-(2-Aminophenyl)-2-formamido-4-oxobutanoic acid
C11H12N2O4 (236.07970319999998)
(Z)-(-)-8-Chloro-6-chloromethyl-3-methoxy-2-methyl-1,6--octadiene
6-Methylflavone
relative retention time with respect to 9-anthracene Carboxylic Acid is 1.300 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.302 6-Methylflavone is an activator of α1β2γ2L and α1β2 GABAA receptors. 6-Methylflavone is an activator of α1β2γ2L and α1β2 GABAA receptors.
Harmalol hydrochloride
Harmalol hydrochloride, a beta carboline alkaloid, presents in several medicinal plants such as Peganum harmala. Harmalol hydrochloride, main metabolite of Harmaline, significantly inhibits the dioxin-mediated induction of CYP1A1 at the transcriptional and posttranslational levels. Harmalol hydrochloride possesses antioxidant and hydroxyl radical-scavenging properties[1]. Harmalol hydrochloride, a beta carboline alkaloid, presents in several medicinal plants such as Peganum harmala. Harmalol hydrochloride, main metabolite of Harmaline, significantly inhibits the dioxin-mediated induction of CYP1A1 at the transcriptional and posttranslational levels. Harmalol hydrochloride possesses antioxidant and hydroxyl radical-scavenging properties[1].
3-O-((R)-1-carboxyethyl)-alpha-L-rhamnose|3-O-<(R)-1-carboxyethyl>-alpha-L-rhamnose|3-O-<(R)-1-carboxyethyl>-L-rhamnose
(2E,6Z)-8-chloro-6-chloromethyl-1-methoxy-2-methylocta-2,6-diene|Me ether-(2E, 6Z)-8-Chloro-6-chloromethyl-2-methyl-2, 6-octadien-1-ol
2,3,4-tri-O-methyl-D-glucuronic acid|2.3.4-Tri-O-methyl-D-glucuronsaeure|O2,O3,O4-trimethyl-D-glucuronic acid|O2,O3,O4-Trimethyl-D-glucuronsaeure
5-methyl-5-(3-oxo-cyclohex-1-enyl)-barbituric acid|5-Methyl-5-(3-oxo-cyclohex-1-enyl)-barbitursaeure|5-methyl-5-(3-oxo-cyclohex-1-enyl)-pyrimidine-2,4,6-trione|5-Methyl-5-<3-oxo-cyclohexen-(1)-yl>-barbitursaeure
C11H12N2O4 (236.07970319999998)
(+)-(S)-2-(3-hydroxy-4-methoxy-2-oxoindolin-3-yl)acetamide
C11H12N2O4 (236.07970319999998)
(S)-6-(1-hydroxypropyl)-3-methyllumazine|Leucettidine
harmalol
Harmalol hydrochloride, a beta carboline alkaloid, presents in several medicinal plants such as Peganum harmala. Harmalol hydrochloride, main metabolite of Harmaline, significantly inhibits the dioxin-mediated induction of CYP1A1 at the transcriptional and posttranslational levels. Harmalol hydrochloride possesses antioxidant and hydroxyl radical-scavenging properties[1]. Harmalol hydrochloride, a beta carboline alkaloid, presents in several medicinal plants such as Peganum harmala. Harmalol hydrochloride, main metabolite of Harmaline, significantly inhibits the dioxin-mediated induction of CYP1A1 at the transcriptional and posttranslational levels. Harmalol hydrochloride possesses antioxidant and hydroxyl radical-scavenging properties[1].
K3JCS9D3KJ
6-Methylflavone is an activator of α1β2γ2L and α1β2 GABAA receptors. 6-Methylflavone is an activator of α1β2γ2L and α1β2 GABAA receptors.
Didanosine
J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AF - Nucleoside and nucleotide reverse transcriptase inhibitors C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97452 - Nucleoside Reverse Transcriptase Inhibitor D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D009676 - Noxae > D000963 - Antimetabolites > D015224 - Dideoxynucleosides D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors C254 - Anti-Infective Agent > C281 - Antiviral Agent Didanosine (2',3'-Dideoxyinosine; ddI) is a a potent and orally active dideoxynucleoside analogue, and also is a potent nucleoside reverse transcriptase inhibitor. Didanosine shows antiretroviral activity for HIV[1][2][3].
Thiacetazone
C10H12N4OS (236.07317819999997)
J - Antiinfectives for systemic use > J04 - Antimycobacterials > J04A - Drugs for treatment of tuberculosis D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D000995 - Antitubercular Agents C254 - Anti-Infective Agent > C52588 - Antibacterial Agent > C280 - Antitubercular Agent
Met-ser
A dipeptide composed of L-methionine and L-serine joined by a peptide linkage.
Ser-met
A dipeptide formed from L-serine and L-methionine residues.
(R)-2-Dimethylamino-1-phenylethylamine
C10H18Cl2N2 (236.08469680000002)
1,3-diisocyanato-2-methylbenzene,ethane-1,2-diol
C11H12N2O4 (236.07970319999998)
dimethyl 5,5-difluorocyclohexane-1,3-dicarboxylate
4-acetamido-3-(diaminomethylideneamino)benzoic acid
3-NITRO-2-PYRROLIDIN-1-YL-BENZOIC ACID
C11H12N2O4 (236.07970319999998)
2-(2,4-difluorobenzoyl)-3-(dimethylamino)acrylonitrile
Methyl 4-(cyclopropylamino)-3-nitrobenzoate
C11H12N2O4 (236.07970319999998)
(R)-4-(1-Aminobutyl)aniline dihydrochloride
C10H18Cl2N2 (236.08469680000002)
3-[(1S)-1-aminoethyl]-N,N-dimethylaniline,dihydrochloride
C10H18Cl2N2 (236.08469680000002)
(S)-4-(1-Aminobutyl)aniline dihydrochloride
C10H18Cl2N2 (236.08469680000002)
(5-Methyl-3-trifluoromethyl-pyrazol-1-yl)-acetic acid ethyl ester
[4-(2-Aminoethyl)phenyl]dimethylaminedihydrochloride
C10H18Cl2N2 (236.08469680000002)
3-[(1R)-1-aminoethyl]-N,N-dimethylaniline,dihydrochloride
C10H18Cl2N2 (236.08469680000002)
1-(3-fluorophenyl)-4-oxocyclohexanecarboxylic acid
4-(4-morpholino)-3-nitrobenzaldehyde
C11H12N2O4 (236.07970319999998)
5-NITRO-2-(1-PYRROLIDINYL)BENZENECARBOXYLIC ACID
C11H12N2O4 (236.07970319999998)
1-(3-NITROPHENYL)-1H-1,2,4-TRIAZOLE
C11H12N2O4 (236.07970319999998)
1-(4-FLUOROPHENYL)-4-OXOCYCLOHEXANECARBOXYLIC ACID
Eflornithine hydrochloride
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D004791 - Enzyme Inhibitors > D065108 - Ornithine Decarboxylase Inhibitors C471 - Enzyme Inhibitor > C2088 - Ornithine Decarboxylase Inhibitor D000970 - Antineoplastic Agents
methyl 5,6-dimethoxy-1h-indazole-3-carboxylate
C11H12N2O4 (236.07970319999998)
1-(2-METHOXYETHYL)-7-METHYL-1H-PYRIDO[2,3-D][1,3]OXAZINE-2,4-DIONE
C11H12N2O4 (236.07970319999998)
5-Chloro-4-piperidin-1-yl-7H-pyrrolo[2,3-d]pyrimidine
1(2H)-Pyridineaceticacid,3-cyano-4-(hydroxymethyl)-6-methyl-2-oxo-,hydrazide(9CI)
3-Amino-4,6-dimethylthieno[2,3-b]pyridine-2-carbohydrazide
C10H12N4OS (236.07317819999997)
3-PHENYL-4,5,6,7-TETRAHYDRO-1,2,3-TRIAZOLO[1,5-A]PYRAZINE HYDROCHLORIDE
1-(2-fluorophenyl)-4-oxocyclohexanecarboxylic acid
1,2-cyclohexanedione, mono[(4-chlorophenyl)hydrazone]
dimethyl 2-(phenylhydrazinylidene)propanedioate
C11H12N2O4 (236.07970319999998)
10-CHLORO-2,3,6,7-TETRAHYDRO-1H-PYRAZINO[2,1-A]ISOQUINOLIN-4(11BH)-ONE
MORPHOLINO(2-NITROPHENYL)METHANONE
C11H12N2O4 (236.07970319999998)
Morpholino(3-nitrophenyl)methanone
C11H12N2O4 (236.07970319999998)
Methanone,4-morpholinyl(4-nitrophenyl)-
C11H12N2O4 (236.07970319999998)
1-(2-NITRO-BIPHENYL-4-YL)-ETHANONE
C11H12N2O4 (236.07970319999998)
1-(5-chloro-1-isopropyl-1H-pyrrolo[2,3-c]pyridin-3-yl)ethanone
1-(7-chloro-1-propan-2-ylpyrrolo[2,3-c]pyridin-3-yl)ethanone
N,N-DIETHYL-1,4-PHENYLENEDIAMINE DIHYDROCHLORIDE
C10H18Cl2N2 (236.08469680000002)
6,7,8-Trimethoxyquinazolin-4(3H)-one
C11H12N2O4 (236.07970319999998)
3-phenyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine
2-Cyanoethyl diisopropylamidochlorophosphite
C9H18ClN2OP (236.08452179999998)
1-(4-NITRO-PHENYL)-AZETIDINE-3-CARBOXYLIC ACID METHYL ESTER
C11H12N2O4 (236.07970319999998)
2-(3-Amino-6-chloroquinolin-2-yl)propan-2-ol
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic
9-[5-(Hydroxymethyl)tetrahydrofuran-2-yl]-9h-purin-6-ol
D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D009676 - Noxae > D000963 - Antimetabolites > D015224 - Dideoxynucleosides D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors
7-phenyl-7H-pyrazolo[4,3-e][1,2,4]triazolo[4,3-c]pyrimidine
Benzenepropanoic acid, alpha-oxo-, trimethylsilyl ester
Carbazochrome
B - Blood and blood forming organs > B02 - Antihemorrhagics > B02B - Vitamin k and other hemostatics D006401 - Hematologic Agents > D003029 - Coagulants > D006490 - Hemostatics C78275 - Agent Affecting Blood or Body Fluid > C78311 - Hemostatic Agent Carbazochrome is a capillary stabiliser and used for the research of haemorrhage. Carbazochrome is an antihemorrhagic agent[1].
2-(dihydroxyamino)-3-(1H-indol-3-yl)propanoic acid
C11H12N2O4 (236.07970319999998)
(2S)-4-(2-Aminophenyl)-2-formamido-4-oxobutanoic acid
C11H12N2O4 (236.07970319999998)
2-Azaniumyl-4-(2-formamidophenyl)-4-oxobutanoate
C11H12N2O4 (236.07970319999998)
L-Homolanthionine
A sulfur-containing amino acid in which the gamma-carbon atoms of two molecules of L-aminobutyric acid are joined via a thioether linkage. It is a byproduct of cystathionine-gamma-lyase and a possible human hyperhomocysteinemia marker.
(2R)-2-ammonio-4-(2-formamidophenyl)-4-oxobutanoate
C11H12N2O4 (236.07970319999998)
COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
(2Z)-2-[[(5-chloropyridin-2-yl)amino]methylidene]cyclohexan-1-one
3-[[(methylsulfonyl)oxy]ethyl]-5,5-dimethyldihydro-2(3H)-furanone
Thiophene-2-carboxaldehyde, (4-amino-5-ethyl-1,2,4-triazol-3-yl)hydrazone
Fructosylglycinate
A glyco-amino-acid anion formed by loss of a proton from the carboxy group of fructosylglycine.
2-Mercapto-4,6-dimethylnicotinonitrile, TMS derivative
Ethane, 1-vinylthio-2-[(trimethylsilyloxy)ethylthio]-
N-formyl-L-kynurenine zwitterion
C11H12N2O4 (236.07970319999998)
Zwitterionic form of N-formyl-L-kynurenine.
N-formyl-D-kynurenine zwitterion
C11H12N2O4 (236.07970319999998)
Zwitterionic form of N-formyl-D-kynurenine having an anionic carboxy group and a protonated amino group; major species at pH 7.3.
MFZ 10-7
MFZ 10-7 is a highly potent and selective mGluR5 NAM (negative allosteric modulator), with a Ki of 0.67 nM for rat mGluR5[1]. MFZ 10-7 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
(2z,6e)-1-chloro-3-(chloromethyl)-8-methoxy-7-methylocta-2,6-diene
2-[(2,3,5-trihydroxy-6-methyloxan-4-yl)oxy]propanoic acid
(2s)-2-{[(2s)-2-amino-1-hydroxy-4-(methylsulfanyl)butylidene]amino}-3-hydroxypropanoic acid
(3s,6z)-8-chloro-6-(chloromethyl)-3-methoxy-2-methylocta-1,6-diene
2-hydroxy-3-[(1s,2s,3r,4r,5s)-1,2,3,4,5-pentahydroxy-2-methylcyclopentyl]propanal
2-hydroxy-6-[(1s)-1-hydroxypropyl]-3-methylpteridin-4-one
(2s)-2-amino-4-{2-[(hydroxymethylidene)amino]phenyl}-4-oxobutanoic acid
C11H12N2O4 (236.07970319999998)
2-hydroxy-3-(1,2,3,4,5-pentahydroxy-2-methylcyclopentyl)propanal
8-chloro-6-(chloromethyl)-3-methoxy-2-methylocta-1,6-diene
8-chloro-6-(chloromethyl)-1-methoxy-2-methylocta-2,6-diene
(2r)-2-hydroxy-2-[4-(methylsulfanyl)butyl]butanedioic acid
2-hydroxy-6-(1-hydroxypropyl)-3-methylpteridin-4-one
(2s)-2-hydroxy-3-[(1s,2s,3r,4r,5s)-1,2,3,4,5-pentahydroxy-2-methylcyclopentyl]propanal
(2r)-2-{[(2r,3r,4r,5s,6s)-2,3,5-trihydroxy-6-methyloxan-4-yl]oxy}propanoic acid
(2s)-2-{[(2s)-2-amino-1,3-dihydroxypropylidene]amino}-4-(methylsulfanyl)butanoic acid
2-[(1-{[hydroxy(methoxy)methylidene]amino}ethylidene)amino]benzoic acid
C11H12N2O4 (236.07970319999998)